Teng M - Search Results

1

Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs.

Lacson E Jr, Ikizler TA, Lazarus JM, Teng M, Hakim RM. Lacson E Jr, et al. Among authors: teng m. J Ren Nutr. 2007 Nov;17(6):363-71. doi: 10.1053/j.jrn.2007.08.009. J Ren Nutr. 2007. PMID: 17971308

2

Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.

Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus JM. Lacson E, et al. Among authors: teng m. Hemodial Int. 2005 Oct;9(4):367-75. doi: 10.1111/j.1492-7535.2005.01155.x. Hemodial Int. 2005. PMID: 16219057

3

The association of race with erythropoietin dose in patients on long-term hemodialysis.

Lacson E Jr, Rogus J, Teng M, Lazarus JM, Hakim RM. Lacson E Jr, et al. Among authors: teng m. Am J Kidney Dis. 2008 Dec;52(6):1104-14. doi: 10.1053/j.ajkd.2008.07.026. Epub 2008 Sep 27. Am J Kidney Dis. 2008. PMID: 18824287

4

Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.

Lacson E Jr, Wang W, Hakim RM, Teng M, Lazarus JM. Lacson E Jr, et al. Among authors: teng m. Am J Kidney Dis. 2009 Jan;53(1):79-90. doi: 10.1053/j.ajkd.2008.07.031. Epub 2008 Oct 18. Am J Kidney Dis. 2009. PMID: 18930570

5

Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis.

Lacson E Jr, Teng M, Lazarus JM, Lew N, Lowrie E, Owen W. Lacson E Jr, et al. Among authors: teng m. Am J Kidney Dis. 2001 Feb;37(2):267-75. doi: 10.1053/ajkd.2001.21288. Am J Kidney Dis. 2001. PMID: 11157366

6

Association between prevalent care process measures and facility-specific mortality rates.

Lowrie EG, Teng M, Lacson E, Lew N, Lazarus JM, Owen WF. Lowrie EG, et al. Among authors: teng m. Kidney Int. 2001 Nov;60(5):1917-29. doi: 10.1046/j.1523-1755.2001.00029.x. Kidney Int. 2001. PMID: 11703611 Free article.

7

The association between mental health, physical function, and hemodialysis mortality.

Knight EL, Ofsthun N, Teng M, Lazarus JM, Curhan GC. Knight EL, et al. Among authors: teng m. Kidney Int. 2003 May;63(5):1843-51. doi: 10.1046/j.1523-1755.2003.00931.x. Kidney Int. 2003. PMID: 12675862 Free article.

8

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Teng M, et al. N Engl J Med. 2003 Jul 31;349(5):446-56. doi: 10.1056/NEJMoa022536. N Engl J Med. 2003. PMID: 12890843 Free article.

9

Toward a continuous quality improvement paradigm for hemodialysis providers with preliminary suggestions for clinical practice monitoring and measurement.

Lowrie EG, Teng M, Lew NL, Lacson EJ, Lazarus JM, Owen WF. Lowrie EG, et al. Among authors: teng m. Hemodial Int. 2003 Jan 1;7(1):28-51. doi: 10.1046/j.1492-7535.2003.00003.x. Hemodial Int. 2003. PMID: 19379340

10

Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival.

Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Williams ME, et al. Among authors: teng m. Kidney Int. 2006 Oct;70(8):1503-9. doi: 10.1038/sj.ki.5001789. Epub 2006 Aug 30. Kidney Int. 2006. PMID: 16941022 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,512 results

Search Page

Filters